PRESENTATION · Sep 2025 · PDF Infigratinib - Hypochondroplasia - Preclinical Improvement in Bone Growth
PUBLICATION · Jun 2025 The Journal of Clinical Investigation, Tyrosine Kinase Inhibitor NVP-BGJ398 Functionally Improves FGFR3-related Dwarfism in Mouse Model
PUBLICATION · Jun 2025 · PDF Journal of Bone and Mineral Research, Infigratinib Low Dose Therapy Is an Effective Strategy to Treat Hypochondroplasia